The chemical class of TNFα-IP 8L3 activators encompasses a diverse range of compounds that can modulate the activity of the protein TNFα-IP 8L3 through their influence on various cellular signaling pathways. The primary mechanism by which these activators operate involves the modulation of the NF-κB pathway, a central regulator of inflammation and immune responses within the cell. By interacting with this pathway, these chemicals can induce changes in the expression levels of TNFα-IP 8L3, thereby affecting its activity. Although the exact mechanisms of action for each chemical may vary, the overall effect is to alter the regulatory functions of TNFα-IP 8L3, which include the control of apoptosis, inflammation, and immune cell function.
These activators are characterized by their ability to engage with intracellular processes that are upstream of TNFα-IP 8L3, thereby initiating a cascade of events that lead to changes in the protein's expression or activity. The modulation of NF-κB by these activators can result in an upregulation of TNFα-IP 8L3, which in turn can have various consequences on cellular behavior. This class of chemicals can include molecules that either inhibit or activate components of the NF-κB pathway, resulting in alterations in the transcriptional activity of genes under the control of this pathway, including those encoding TNFα-IP 8L3. The ability to modulate such a critical pathway illustrates the significant role these chemicals can play in the regulation of TNFα-IP 8L3 and its associated cellular functions.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $102.00 $204.00 | 13 | |
Inhibits NF-κB activation and could thus influence TNFAIP8L3 expression and function. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $158.00 | 6 | |
Inhibits NF-κB signaling and may affect TNFAIP8L3 function in inflammatory pathways. | ||||||